A holistic approach to managing Acute effects of empagliflozin on open‑loop AMD Cure Palliative 2025 AMD SID Telemonitoraggio Consusens 2024 Cardio Renal-Metabolic Overlap Cardiovascular and Renal Outcomes with Empagliflozin Cost‑Effectiveness Analysis of SGLT2 Inhibitors SID AMD USO COMPASSIONEVOLE TEPLIZUMAB dicembre 2024 AMD Cure Palliative 2025 Empagliflozin and Progression of Kidney Empagliflozin attuali indicazioni Empagliflozin in Patients with Chronic LG_196_La terapia del diabete di tipo 1 Ed 2024 giu nota-100 RACCOMANDAZIONI PER LA PROFILASSI VACCINALE SGLT‑2 inhibitors and cardiorenal outcomes The cardio‑renal‑metabolic connection The effect of DPP‑4 inhibitors, GLP‑1 The Impact of Cardio-Renal-Metabolic Profile in Dilated Versione-finale-documento-OMS-vers.10.10.24
